Global Market Overview - The Hang Seng Index closed at 26,086, down 0.43% for the day but up 30.04% year-to-date [1] - The Shanghai Composite Index rose by 1.65% to 3,875, with a year-to-date increase of 15.62% [1] - The US markets saw the Dow Jones increase by 1.36% to 46,108, with a year-to-date gain of 8.38% [1] Sector Performance - In the Hong Kong market, the healthcare, energy, and consumer discretionary sectors led the decline, while materials, utilities, and industrials saw gains [3] - The semiconductor and rare metals sectors performed notably well, with significant inflows from southbound funds amounting to HKD 189.89 billion [3] Economic Indicators - The European Central Bank (ECB) maintained interest rates and revised down its inflation forecast for 2027 to 1.9% [3] - The US Consumer Price Index (CPI) showed a month-on-month increase of 0.4% and a year-on-year increase of 2.9%, aligning with market expectations [3] Investment Recommendations - Geely Automobile is rated as a "Buy" with a target price of HKD 25.00, representing a potential upside of 33% [4] - Luckin Coffee is also rated as a "Buy" with a target price of USD 44.95, indicating a 19% upside [4] - Semiconductor companies like Horizon Robotics and Beike Micro are rated as "Buy" with target prices of HKD 12.30 and HKD 93.00, respectively, showing potential upsides of 19% and 76% [4]

Core Viewpoint - UBS downgraded China Resources Beverage from "Buy" to "Neutral" due to reasonable valuation, lowering the target price from HKD 18.03 to HKD 11.7 [1] Financial Performance - For the first half of the year, China Resources Beverage reported a revenue decline of 19% and a net profit decrease of 29%, both below market expectations [1] - The revenue from the packaged water segment decreased by 23% year-on-year, while the beverage segment saw a revenue increase of 21% [1] Business Segment Analysis - The decline in bottled water revenue is attributed to increased rebates for distributors [1] - As the negative impacts of channel restructuring gradually dissipate, it is expected that bottled water sales will begin to recover in the second half of the year [1] Future Outlook - Looking ahead to 2026, UBS anticipates a potential turnaround in profitability due to sustained strong growth in the beverage segment and expected growth in bottled water sales [1]

9月9日，2025年度Wind中国上市公司"ESG最佳实践100强"榜单重磅发布。珍酒李渡凭借在ESG领域的持续深耕，继2023、2024年后再度入选，并连 续三年成为榜单唯一入选白酒企业，达成"三连冠"佳绩。 Wind ESG评级体系作为国内ESG评级领域的佼佼者，其评级结果与底层数据覆盖了A+H股上市公司，公募信用债发债主体和国内公募基金等超2万 家市场主体，是国内外资产管理机构投资决策的重要参考。"ESG最佳实践100强"榜单则代表了中国上市公司在ESG领域的最高水平。 2025年，珍酒李渡Wind ESG评级实现重大突破，从AA级跃升至最高评级AAA级，不仅稳居白酒行业第一，也在中国饮料企业中排名第一。数据显 示，截至2025年9月1日，A+H股上市公司中，ESG评级达AAA级的公司占比仅为0.34%。 | 海天味业(603288.SH, 3288.HK) | AA | 日常消费 | | --- | --- | --- | | 万洲国际 (0288.HK) | AA | 日常消费 | | 华润啤酒(0291.HK) | AA | 日常消费 | | 蒙牛乳业(2319.HK) | AA | 日常消费 | ...

中金发表报告指，华润饮料上半年业绩符合该行预期，收入62.06亿元，按年下跌18.5%，净利润8.05亿 元，按年跌28.6%。业绩符合此前预告。 该行预计，下半年公司丰富产品矩阵、深化渠道变革的调整有望延续，认为短期调整是为长期发展蓄 力。该行预计进入饮料旺季后公司经营状况有所改善，7至8月包装水及饮料销量或均实现按年增长。考 虑渠道竞争持续激烈，预计下半年公司或将保持渠道及终端费用的高投入，以稳固市场份额。 考虑行业竞争加剧，该行下调华润饮料2025/2026年盈利预测18%/2%至10.9/15.3亿元，下调目标价29% 至12港元，维持"跑赢行业"评级。 ...

Group 1: Market Overview - Global markets showed mixed performance, with the Hang Seng Index rising by 1.43% and the S&P 500 declining by 0.32% year-to-date [1][3] - The Chinese stock market saw significant gains, particularly in sectors like materials, healthcare, and industrials, with net inflows of 56.23 billion HKD from southbound funds [3][4] - The U.S. labor market showed signs of weakness, with non-farm payrolls increasing by only 22,000 in August, leading to heightened expectations for interest rate cuts by the Federal Reserve [4][5] Group 2: Industry Insights - The pharmaceutical industry experienced overall weak growth, with average revenue growth of 1.6% and net profit declining by 3.2% in the first half of 2025 [6][8] - The innovative drug sector performed well, with an average revenue growth of 35%, driven by favorable healthcare payment environments and international licensing agreements [6][8] - The CXO sector saw a revenue increase of 15.5% and net profit growth of 32.7%, primarily due to strong demand for GLP-1 products [7][8] Group 3: Company Analysis - Broadcom reported a revenue of 16 billion USD for Q3 2025, exceeding market expectations, with a year-on-year growth of 22% driven by AI semiconductor and VMware business [9][10] - Black Sesame Technologies achieved a revenue of 253 million HKD in the first half of 2025, a 40% increase, although gross margins were under pressure due to unfavorable product mix [11] - The report recommends buying shares in companies like 三生制药 (Sangfor Technologies) and 百济神州 (BeiGene), highlighting their potential for growth in the pharmaceutical sector [12]

Market Overview - The global stock markets showed mixed performance, with the Hang Seng Index closing at 25,059, down 1.12% for the day but up 24.92% year-to-date [1] - The US markets, including the Dow Jones and S&P 500, experienced gains of 0.77% and 0.83% respectively, while the Nasdaq rose by 0.98% [1] - Chinese stock markets faced declines, particularly in hardware technology, with the Shenzhen Composite Index down 2.05% [1][3] Sector Performance - In the Hong Kong market, the Hang Seng Financial Index decreased by 0.42%, while the Hang Seng Industrial Index fell by 1.58% [2] - The hardware technology sector in China led the declines, while sectors such as retail and food saw gains [3] - The US market saw a rise in consumer discretionary, banking, and solar sectors, while utilities and AI-related stocks lagged [3] Company Analysis - Salesforce reported a 10% year-on-year revenue growth to $10.2 billion for Q2 FY26, with non-GAAP net profit increasing by 12% to $2.8 billion, aligning with Bloomberg consensus [4] - The company’s cRPO grew by 11% to $29.4 billion, driven by strong orders from small and medium-sized enterprises [4] - Salesforce's AI and data cloud business saw an impressive annual recurring revenue growth of approximately 120% [4] Investment Recommendations - The report maintains a "Buy" rating for several companies, including Geely Automobile, Li Auto, and Tencent, with target prices indicating significant upside potential [5] - Geely Automobile is rated "Buy" with a target price of 25.00 HKD, representing a 37% upside from its current price of 18.24 HKD [5] - Tencent is also rated "Buy" with a target price of 705.00 HKD, suggesting an 18% upside from its current price of 599.50 HKD [5]

致：香港交易及結算所有限公司 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年8月31日 狀態: 新提交 公司名稱: 華潤飲料（控股）有限公司 呈交日期: 2025年9月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02460 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 100,000,000,000 | USD | | 0.0000005 | USD | | 50,000 | | 增加 / 減少 (-) | | | | | | | USD | | | | 本月底結存 | | | 100,000,000,000 | USD | | 0.0000005 | USD | | 50,000 | 本月 ...

Core Viewpoint - Goldman Sachs reports that China Resources Beverage will continue to push for channel reform, advance investments in new channels and products, and increase market share in packaged water in the second half of the year. This strategy may pressure short-term profits but is expected to achieve sustainable growth and business diversification in the long term [1] Financial Projections - The bank forecasts net profits of 1.08 billion yuan and 1.37 billion yuan for 2025 and 2026, respectively, with a 27% year-on-year rebound in 2026 due to sales recovery, leverage effects, and normalization of investment scale [1] - For the second half of this year, the bank estimates a net profit of 261 million yuan, a 48% year-on-year decline, attributed to increased upfront investments during the traditional off-season [1] Target Price and Rating - The target price for the company has been revised down from 12.1 HKD to 10.5 HKD, maintaining a "neutral" rating [1]

Core Viewpoint - The company's 1H25 performance met expectations, with revenue of 6.206 billion yuan, down 18.5% year-on-year, and net profit attributable to shareholders of 805 million yuan, down 28.6% year-on-year [1]. Group 1: Packaging Water Business - The packaging water business is under pressure due to intensified industry competition, with revenue declining 23.1% year-on-year to 5.25 billion yuan [2]. - Factors contributing to the decline include increased promotional competition, channel reform adjustments, and operational rhythm impacts from 1H24 [2]. - Despite the overall decline, the company's retail sales growth in packaging water outperformed the industry, with market share increasing by 0.5 percentage points to 19.3% compared to the end of 2024 [1]. Group 2: Beverage Business - Beverage revenue grew by 21.3% year-on-year to 950 million yuan, driven by a focus on tea, juice, and sports drinks, and the introduction of 14 new SKUs in the first half of the year [2]. - The company is responding to consumer trends by implementing a large packaging strategy to alleviate price competition pressures [2]. Group 3: Financial Metrics and Profitability - The company's gross margin decreased by 2.6 percentage points to 46.7%, primarily due to the underperformance of the packaging water business, while the beverage segment saw an improvement in gross margin [2]. - Selling expenses increased by 2.9 percentage points to 30.4% due to higher marketing and channel expenses to address intensified competition [2]. - The net profit margin decreased by 1.8 percentage points to 13%, indicating pressure on profitability due to declining gross margins and increased expenses [2]. Group 4: Future Outlook - The company is expected to continue adjustments in product matrix and channel reforms in the second half of the year, which are seen as preparations for long-term growth [3]. - An improvement in operational conditions is anticipated during the beverage peak season, with expectations of year-on-year growth in both packaging water and beverage sales in July and August [3]. - Profitability forecasts for 2025 and 2026 have been revised down by 18% and 2% to 1.09 billion yuan and 1.53 billion yuan, respectively, with a target price reduction of 29% to 12 HKD [3].

Market Overview - Global markets showed mixed performance, with the Hang Seng Index closing at 25,343, down 0.60% for the day but up 26.34% year-to-date [1] - The Shanghai Composite Index fell by 1.16% to 3,814, while the Shenzhen Composite Index decreased by 1.41% to 2,380 [1] - In the US, the Dow Jones Industrial Average decreased slightly by 0.05% to 45,271, while the S&P 500 rose by 0.51% to 6,448 [1] Sector Performance - The Hang Seng Financial Index fell by 0.72% to 44,195, while the Hang Seng Real Estate Index dropped by 1.23% to 18,116 [2] - The healthcare sector showed resilience, with medical devices and innovative drugs performing well [3] Company Analysis: VILIZHIBO (9887 HK) - VILIZHIBO focuses on developing next-generation immuno-oncology therapies, with a broad product pipeline including immune checkpoint inhibitors and T-cell engagers [4] - The company has established proprietary platforms for drug innovation, including the LeadsBody platform for CD3 T-cell engagers and the X-body platform for 4-1BB agonists [4] - LBL-024, targeting PD-L1/4-1BB, is in the registration clinical stage and shows promising clinical data, with an overall response rate (ORR) of 33.3% in specific cancer patients [5] Company Analysis: China Life (2628 HK) - China Life reported a net profit increase of 7% to 40.9 billion RMB for the first half of 2025, despite a 31% decline in Q2 due to rising insurance service costs [7] - The new business value grew by 20.3% to 28.5 billion RMB, driven by significant growth in bancassurance channels [8] - The company’s core equity assets increased, benefiting from realized capital gains and dividend income [8] Company Analysis: JS Global (1691 HK) - JS Global's SharkNinja brand continues to see high growth in the Asia-Pacific region, with market share in Australia and New Zealand increasing significantly [10] - The company is shifting focus from scale to profitability, with expectations of improved gross and net margins due to product upgrades and SKU optimization [11] - Despite a slight decline in sales, the company anticipates a recovery in overseas sales and improved profitability in the coming years [12]